We are live on
!
Find out more
ECG
EPIQ Capital Group Portfolio holdings
AUM
$383M
1-Year Est. Return
46.87%
This Fund
S&P 500
This Quarter
Est. Return
+9.1%
1 Year Est. Return
+46.87%
3 Year Est. Return
-6.25%
5 Year Est. Return
+38.91%
10 Year Est. Return
–
AUM
$957M
AUM Growth
+$61.7M
(+6.9%)
Cap. Flow
+$41.9M
Cap. Flow
% of AUM
4.38%
Top 10 Holdings %
Top 10 Hldgs %
93.83%
Holding
56
New
6
Increased
27
Reduced
10
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$34.4M |
| 2 |
Quince Therapeutics
QNCX
|
+$4.6M |
| 3 |
AMTI
Applied Molecular Transport Inc. Common Stock
AMTI
|
+$3.16M |
| 4 |
Coinbase
COIN
|
+$2.12M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$567K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$1.18M |
| 2 |
Salesforce
CRM
|
+$1.02M |
| 3 |
TLND
Talend S.A. American Depositary Shares
TLND
|
+$971K |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$405K |
| 5 |
Netflix
NFLX
|
+$357K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 72.08% |
| 2 | Miscellaneous | 19.22% |
| 3 | Communication Services | 4.48% |
| 4 | Consumer Discretionary | 3.28% |
| 5 | Financials | 0.36% |
Similar funds
BCA
SAM
GJCM
AP
FWM
BW
WWP
CIM
EPIQ Capital Group's Q2 2021 Portfolio in Review
As of Q2 2021, EPIQ Capital Group held 56 positions worth $957M, up 6.9% from $896M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
EPIQ Capital Group deployed $41.9M of net new capital in Q2 2021, opening 6 new positions and adding to 27 existing holdings. Its largest new stake was Applovin: 498,208 shares worth $37.5M.
By sector, the portfolio is most concentrated in Healthcare at 72% of assets, down from 75% a quarter earlier, followed by Miscellaneous and Communication Services.
On the sell side, the largest reduction was iShares Russell 1000 ETF, an estimated $1.18M trimmed.
- EPIQ Capital Group's largest Q2 2021 buy was Applovin: 498,208 shares worth $37.5M.
- EPIQ Capital Group added most to Quince Therapeutics in Q2 2021, an estimated $4.6M increase.
- EPIQ Capital Group's biggest Q2 2021 reduction was iShares Russell 1000 ETF, cutting an estimated $1.18M.
- EPIQ Capital Group fully exited Talend S.A. American Depositary Shares in Q2 2021, selling an estimated $971K.
- EPIQ Capital Group's ten largest holdings make up 94% of its $957M portfolio in Q2 2021.
- EPIQ Capital Group opened 6 new positions and closed 1 in Q2 2021.
- EPIQ Capital Group's portfolio value rose 6.9% quarter-over-quarter to $957M.
Based on EPIQ Capital Group's 13F filing for Q2 2021, filed 30 Jul 2021.